These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35959378)

  • 1. Emerging advances in identifying signal transmission molecules involved in the interaction between
    Wang Y; Shi Q; Chen Q; Zhou X; Yuan H; Jia X; Liu S; Li Q; Ge L
    Front Cell Infect Microbiol; 2022; 12():956311. PubMed ID: 35959378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis.
    Mortaz E; Adcock IM; Tabarsi P; Masjedi MR; Mansouri D; Velayati AA; Casanova JL; Barnes PJ
    J Clin Immunol; 2015 Jan; 35(1):1-10. PubMed ID: 25312698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity in tuberculosis: host defense vs pathogen evasion.
    Liu CH; Liu H; Ge B
    Cell Mol Immunol; 2017 Dec; 14(12):963-975. PubMed ID: 28890547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword?
    Hossain MM; Norazmi MN
    Biomed Res Int; 2013; 2013():179174. PubMed ID: 24350246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving biology of
    Jones RM; Adams KN; Eldesouky HE; Sherman DR
    Front Cell Infect Microbiol; 2022; 12():1027394. PubMed ID: 36275024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
    Kiran D; Podell BK; Chambers M; Basaraba RJ
    Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis.
    Chai Q; Wang L; Liu CH; Ge B
    Cell Mol Immunol; 2020 Sep; 17(9):901-913. PubMed ID: 32728204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis PPE51 Inhibits Autophagy by Suppressing Toll-Like Receptor 2-Dependent Signaling.
    Strong EJ; Wang J; Ng TW; Porcelli SA; Lee S
    mBio; 2022 Jun; 13(3):e0297421. PubMed ID: 35467412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latest Comprehensive Knowledge of the Crosstalk between TLR Signaling and Mycobacteria and the Antigens Driving the Process.
    Kim JS; Kim YR; Yang CS
    J Microbiol Biotechnol; 2019 Oct; 29(10):1506-1521. PubMed ID: 31581380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies Employed to Evade the Host Immune Response and the Mechanism of Drug Resistance in
    Sheikh BA; Bhat BA; Ahmad Z; Mir MA
    Curr Pharm Biotechnol; 2022; 23(14):1704-1720. PubMed ID: 34951359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Host Pattern Recognition Receptors (PRRs) with Mycobacterium Tuberculosis and Ayurvedic Management of Tuberculosis: A Systemic Approach.
    Ponnusamy N; Arumugam M
    Infect Disord Drug Targets; 2022; 22(2):e130921196420. PubMed ID: 34517809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological and protective roles of dendritic cells in
    Kim H; Shin SJ
    Front Cell Infect Microbiol; 2022; 12():891878. PubMed ID: 35967869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensing of Mycobacterium tuberculosis and consequences to both host and bacillus.
    Stamm CE; Collins AC; Shiloh MU
    Immunol Rev; 2015 Mar; 264(1):204-19. PubMed ID: 25703561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to
    Dubé JY; Fava VM; Schurr E; Behr MA
    Front Immunol; 2021; 12():714808. PubMed ID: 34276708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloid C-Type Lectin Receptors in Tuberculosis and HIV Immunity: Insights Into Co-infection?
    Naqvi KF; Endsley JJ
    Front Cell Infect Microbiol; 2020; 10():263. PubMed ID: 32582566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bag it, tag it: ubiquitin ligases and host resistance to Mycobacterium tuberculosis.
    Campos PC; Cunha DT; Souza-Costa LP; Shiloh MU; Franco LH
    Trends Microbiol; 2022 Oct; 30(10):973-985. PubMed ID: 35491351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
    Park HE; Lee W; Shin MK; Shin SJ
    Front Immunol; 2021; 12():703060. PubMed ID: 34262571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.